President Trump called the TrumpRx platform one of the most transformative healthcare initiatives. A month after launch, few drugs are available on the platform, usage data is unknown, and private deals with pharmaceutical companies are still being finalized.[1][3] The platform offers discounts on drugs directly from manufacturers, but its prices are not the lowest in the world, as government officials claim.[5] According to a KFF poll, 41% of Americans think the Trump administration's policies will lower their drug costs, with 79% of Republicans and 11% of Democrats expecting it.[2] Biotech companies criticize Trump's plan to cap drug prices at the lowest level in rich countries because it threatens their innovation.[2][6] The administration is using efforts to lower drug prices as a key argument ahead of the midterm elections.[1][3]